Franklin Resources
IMMX icon

Franklin Resources’s Immix Biopharma IMMX Stock Holding History

Franklin Resources’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.99M Buy
969,120
+54
+0% +$501 ﹤0.01% 1280
2026
Q1 		$8.83M Sell
969,066
-11,326
-1% -$83.2K ﹤0.01% 1286
2025
Q4 		$5.13M Buy
+980,392
New +$4.03M ﹤0.01% 1392

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Franklin Resources's IMMX Position: Q2 2026 in Review

Franklin Resources increased its Immix Biopharma (IMMX) stake by 0.01% in Q2 2026, buying an estimated $501 and bringing the position to 969,120 shares worth $9.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Franklin Resources first reported a position in IMMX in Q4 2025 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Franklin Resources held 969,120 shares of Immix Biopharma worth $9.99M as of Q2 2026.
  • Franklin Resources bought 54 Immix Biopharma shares in Q2 2026, an estimated $501.
  • Immix Biopharma made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1280 holding.
  • Franklin Resources first reported a position in Immix Biopharma in Q4 2025 and has held it in 3 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.